phase readout
saveNCT03737981: Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that